Insider Trading & Ownership of Benjamin C. Smeal
-
Location
-
Walnut Creek, CA
-
Signature
-
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Benjamin C. Smeal
Follow Filing Activity
Follow Benjamin C. Smeal and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Benjamin C. Smeal has 1 issuer position tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Evoke Pharma Inc ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Benjamin C. Smeal
| Symbol |
Company |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Report Period |
| EVOK |
Evoke Pharma Inc |
Director |
|
|
|
17 Dec 2025 |
Insider Transactions Reported by Benjamin C. Smeal:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.